Citation: K. Wild et J. Kaye, RATE OF PROGRESSION IN THE LATER STAGES OF ALZHEIMER-DISEASE - EVIDENCE FROM THE SEVERE IMPAIRMENT BATTERY, Clinical neuropsychologist, 12(2), 1998, pp. 281-281
Authors:
PANKHANIYA R
JABRANEFERRAT N
GAUFO GO
SREEDHARAN SP
DAZIN P
KAYE J
GOETZL EJ
Citation: R. Pankhaniya et al., VASOACTIVE-INTESTINAL-PEPTIDE ENHANCEMENT OF ANTIGEN-INDUCED DIFFERENTIATION OF A CULTURED LINE OF MOUSE THYMOCYTES, The FASEB journal, 12(1), 1998, pp. 119-127
Citation: Am. Orourke et al., CUTTING EDGE - A ROLE FOR P21(RAS) KINASE IN TCR-MEDIATED ACTIVATION OF LFA-1, The Journal of immunology (1950), 161(11), 1998, pp. 5800-5803
Citation: J. Ochoagaray et al., NUCLEAR FACTOR KAPPA-B IS REQUIRED FOR PEPTIDE ANTIGEN-INDUCED DIFFERENTIATION OF A CD4(+)CD8(+) THYMOCYTE LINE, The Journal of immunology, 160(8), 1998, pp. 3835-3843
Authors:
GALASKO D
CHANG L
MOTTER R
CLARK CM
KAYE J
KNOPMAN D
THOMAS R
KHOLODENKO D
SCHENK D
LIEBERBURG I
MILLER B
GREEN R
BASHERAD R
KERTILES L
BOSS MA
SEUBERT P
Citation: D. Galasko et al., HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE, Archives of neurology, 55(7), 1998, pp. 937-945
Authors:
GAUFO GO
PANKHANIYA RR
KAYE J
SREEDHARAN SP
GOETZL EJ
Citation: Go. Gaufo et al., VASOACTIVE-INTESTINAL-PEPTIDE TYPE-II RECEPTOR-SPECIFIC ENHANCEMENT OF MOUSE THYMOCYTE DIFFERENTIATION TO CD4(-CELLS() SINGLE POSITIVE T), The FASEB journal, 11(9), 1997, pp. 400-400
Authors:
ZAREPARSI S
KAYE J
CAMICIOLI R
GRIMSLID H
OKEN B
LITT M
NUTT J
BIRD T
SCHELLENBERG G
PAYAMI H
Citation: S. Zareparsi et al., MODULATION OF THE AGE AT ONSET OF PARKINSONS-DISEASE BY APOLIPOPROTEIN-E GENOTYPES, Annals of neurology, 42(4), 1997, pp. 655-658
Authors:
PINCUS T
LARSEN A
BROOKS RH
KAYE J
NANCE EP
CALLAHAN LF
Citation: T. Pincus et al., COMPARISON OF 3 QUANTITATIVE MEASURES OF HAND RADIOGRAPHS IN PATIENTSWITH RHEUMATOID-ARTHRITIS - STEINBROCKER STAGE, KAYE MODIFIED SHARP SCORE, AND LARSEN SCORE, Journal of rheumatology, 24(11), 1997, pp. 2106-2112
Authors:
GOLDMAN S
DAVENPORT V
REAMAN G
LAVER J
KREISSMAN S
BLAZAR B
BERG S
KAYE J
PATTERSON F
CAIRO MS
Citation: S. Goldman et al., COMBINATION OF RHIL-11-CSF ENHANCES PLATELET (PLT) AND MYELOID RECOVERY FOLLOWING IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (ICE) CHEMOTHERAPYIN CHILDREN WITH SOLID TUMORS (ST) - RHIL-11 IS WELL TOLERATED AT DOUBLE THE ADULT RECOMMENDED DOSE(G), Experimental hematology, 25(8), 1997, pp. 201-201
Authors:
PAUL O
ARNOLD CB
MANDRIOTA R
AMES RP
EISENBACH JR
BOHN E
THOMAS HE
KANNEL WB
ROTONDO R
CONNORS J
BRAND FN
SMITH LK
PRISCO MT
GREENE P
KEZDI P
STANLEY EL
BLACK WL
ERNST FA
CASE EJ
BENTLEY V
COVERT D
LUCIUS M
PARIS F
SEMMETT R
SKOTKO L
CHRISTAKIS G
BURR JM
GERACE TA
WILCOX ME
BRAMSON D
BENEZRA J
WEDDLE J
KAYE J
PADRON M
RAUTAHARJU PM
WOLF H
BENFARI RC
MCINTYRE KM
DANIELSON E
OCKENE J
KOUSCHHOWARD D
BALDWIN AD
WILD JB
GREENLICK M
GROVER J
LAMB S
BAILEY J
DYER J
BROKOP B
STEVENS V
BAILEY G
HOLMES W
PICKERING JE
ALLAIRE J
DUFFY EL
FELLON D
FEINSTEIN B
HUTCHINS D
RUBEL G
COOPER GR
BAYSE DD
MILLER DT
HAINLINE A
KUCHMAK M
WIEBE DA
WINN CL
TAYLOR L
BOTERO BL
GILL JB
LASSER NL
HYMOWITZ N
MEZEY KC
MUNVES B
PARELL E
BURGIO S
LASSER V
JOHNSON B
JEFFREY S
RICE E
STAMLER J
MOSS D
PERSKY V
ROBINSON E
VANHORN L
SHANNON K
MEYERS D
COHEN L
MORGAN J
GRUNDMANN G
VESTAL TD
HUANG B
BERKSON DM
LAUGER G
GRUJIC S
OBRADOVIC D
PARDO E
DUA S
MCGOWAN S
BILLINGS J
HULLEY SB
SMITH WM
SYME SL
COHEN R
DZVONIK L
ROOS L
KAHN M
WIDDOWSON GM
WILLIAMS GZ
KUEHNEMAN ML
SCHOENBERGER JA
SCHOENENBERGER JC
SHEKELLE RB
NERI GS
DOLECEK T
BETZ E
SKWERES L
OPPENHEIMER F
GERNHOFER N
HARDY GG
MCGILL E
HALL Y
WRIGHT NH
KOPEL SA
SUCKERMAN KR
SCHORIN M
SIMON N
COHEN JD
BUNKERS E
RONCHETTO B
GRODSKY E
FRESSOLA A
DANIELGENTRY J
TREIMAN R
SULLIVAN W
SCHNAPER HW
HUGHES GH
OBERMAN A
HILL CC
ALLEN R
BRAGG C
STOKES S
JOHNSON P
BORHANI NO
SUGARS C
KIRKPATRICK K
LEE M
DEBOURELANDO S
LABAW F
TURNERTUCKER J
SHERWIN RW
SEXTON MS
CUSACK NE
DEBARROS QTF
DISCHINGER PC
SPIZLER JF
HEINER JD
PILKINGTON MB
SCANLON BL
GRIMM RH
MITTELMARK M
CROW RS
BLACKBURN H
JACOBS D
RAINS D
MCDONALD M
LENZ K
PRINEAS RJ
CROW RC
BUZZARD IM
GRAMBSCH PV
WENZ J
KJELSBERG MO
BARTSCH GE
NEATON JD
AUS BM
BENDICKSON J
BROSTE SK
CONNETT JE
DUCHENE AG
DURKIN DA
GORDER DL
GRANDITS GA
HULTGREN DH
KNICKERBOCKER A
RASMUSSEN WL
SVENDSEN KH
WILLE L
KULLER LH
MCDONALD R
CAGGIULA A
FALVOGERARD L
MEILAHN E
MILAS NC
RUSSELL R
HORBIAK J
ALMAN M
SOUTHWICK K
MOYER R
GAHAGAN E
GIESE WK
MARTIN JF
KEITH JA
HARRISON HH
MATHIS DE
BROWN CK
FISHMAN E
WAMPLER L
NEWMARK G
ROSENFIELD F
SIDDIQUI S
SAVAGE W
BRADFORD A
INSULL W
FARQUHAR JW
JENKINS CD
RAPAPORT E
THOMPSON DJ
TYROLER HA
WILLIS PW
FRIEDEWALD WT
ZUKEL W
DOYLE JT
BURCHELL HB
YU PN
WILLIS PW
FURBERG CD
CUTLER JA
ZUKEL WJ
PASSAMANI ER
KAELBER CT
FARRAND ME
TILLOTSON JL
VERTER JI
WU MC
GORDON T
HALPERIN M
MCGEE DL
BLASZKOWSKI TP
EBERLEIN KA
HARRIS CE
DERN PL
FRIEDMAN LM
MAY GS
VARGOSKO AJ
Citation: O. Paul et al., MULTIPLE RISK FACTOR INTERVENTION TRIAL - RISK FACTOR CHANGES AND MORTALITY RESULTS (REPRINTED FROM JAMA, VOL 248, PG 1465-1477, 1982), JAMA, the journal of the American Medical Association, 277(7), 1997, pp. 582-594
Authors:
PAYAMI H
SCHELLENBERG GD
ZAREPARSI S
KAYE J
SEXTON GJ
HEAD MA
MATSUYAMA SS
JARVIK LF
MILLER B
MCMANUS DQ
BIRD TD
KATZMAN R
HESTON L
NORMAN D
SMALL GW
Citation: H. Payami et al., EVIDENCE FOR ASSOCIATION OF HLA-A2 ALLELE WITH ONSET AGE OF ALZHEIMERS-DISEASE, Neurology, 49(2), 1997, pp. 512-518
Authors:
PAYAMI H
SCHELLENBERG G
ZAREPARSI S
KAYE J
SEXTON G
HEAD MA
MATSUYAMA S
JARVIK L
MILLER B
MCMANNUS D
BIRD T
KATZMAN R
HESTON L
NORMAN D
SMALL G
Citation: H. Payami et al., ASSOCIATION OF HLA-A2 ALLELE WITH ONSET AGE OF ALZHEIMER-DISEASE, Neurology, 48(3), 1997, pp. 4004-4004
Authors:
SEUBERT PA
MOTTER RN
SCHENK DB
LIEBERBURG IM
KHOLODENKO D
GALASKO D
THOMAS R
CHANG L
MILLER B
CLARK C
KNOPMAN DS
KAYE J
GREEN RC
KERTILES L
BASHIRZADEH R
BOSS MA
Citation: Pa. Seubert et al., APOE GENOTYPE INFLUENCES THE CSF LEVEL OF A-BETA-42 IN ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63006-63006
Authors:
GALASKO D
SEUBERT P
MOTTER R
SCHENK D
KHOLODENKO D
LIEBERBURG I
CHANG L
MILLER B
CLARK C
KAYE J
CAMICIOLI R
KNOPMAN D
GREEN RC
THOMAS R
KERTILES L
BOSS M
Citation: D. Galasko et al., CSF LEVELS OF A-BETA-432 AND TAU AS AIDS TO DIAGNOSING ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63008-63008
Citation: H. Shao et al., CUTTING EDGE - A ROLE FOR RAS SIGNALING IN CORECEPTOR REGULATION DURING DIFFERENTIATION OF A DOUBLE-POSITIVE THYMOCYTE CELL-LINE, The Journal of immunology, 159(12), 1997, pp. 5773-5776